Top Tweets for #Cellavidity
Looking for the right tool to identify and validate effective cell therapies? Watch this video on how #cellavidity measurements with the z-Movi Cell Avidity Analyzer may significantly accelerate cell product development.⬇️
https://t.co/sE2YMPNSu2
#CARNK therapy shows promise for #solidtumors, but finding the most effective candidate can be challenging due to discrepancies between in vitro and in vivo outcomes. Discover how #cellavidity is the most reliable biomarker to assess #CARNK efficacy! ⬇️
https://t.co/8M6gSrhPAd
Measuring #cellavidity enabled scientists to identify robust #CAR #NKs that efficiently kill #solidtumors. Enhanced avidity in #CARNKtherapies using a #molecularanchor helps fine-tune #synapticinteractions. Learn how #avidity can transform #CARNK design: https://t.co/qbLlrZXbEl
Looking for a fast and simple way to separate your #cellengager constructs? #Cellavidity measurement is an innovative and reproducible approach that allows researchers to rank #cellengagers by quantifying cell-to-cell binding events. Find out more:⬇️
https://t.co/GkZ1HmN0Nd
Significant breakthrough in #CARNK research! A study published @NatureBiotech describes how enhancing #cellavidity in #CARNKs through #synapse tuning leads to increased #anticancer activity. Discover how to optimize your #CARNKtherapies⬇️
https://t.co/yrYp5e0Srl
Measuring #cellavidity enabled scientists to identify robust #CAR#NKs that efficiently kill solid tumors. Enhanced avidity in CAR-NK therapies using a molecular anchor helps fine-tune synaptic interactions. Learn how avidity can transform CAR-NK design 👉 https://t.co/UsyeGzDAfH
Measuring #cellavidity enabled scientists to identify robust #CAR#NKs that efficiently kill solid tumors. Enhanced avidity in CAR-NK therapies using a molecular anchor helps fine-tune synaptic interactions. Learn how avidity can transform CAR-NK design 👉 https://t.co/UsyeGzDAfH
A recent #NatureBiotech paper shows how enhanced #cellavidity through synapse tuning is essential when building new #CAR #NKs.⬇️
https://t.co/1bUZ5yJ3A1
Visit booth #8 at the 5th @EHA_Hematology #CARTcellmeeting to find out how #cellavidity can be applied to your research.
On #WorldCancerDay, let's recognize how LUMICKS has been making an impact on cancer research development. Using #cellavidity technology, researchers identified the resistance mechanisms to evade #CARTcell cytotoxicity in solid tumors.
Learn more here:⬇️
https://t.co/f2AFj2KoVC
New improvements for synapse tuning in #CAR #NK design leading to the potential for more robust #cancertreatments. A new @NatureBiotech paper published today describes how enhanced #cellavidity is essential when building new CAR NKs. Read more here: ⬇️
https://t.co/4c3sF9cxaV
Proper immune synapse formation is required to initiate #Tcell activation and subsequent activities leading to tumor cell killing. Learn how #cellavidity measurements can help you define the total interaction strength at the immune synapse interface.⬇️
https://t.co/UsdkH0SxdK
From 5 to 8 December we will be at #BSI22 in Liverpool! Swing by booth #34 to learn all about #cellavidity and how measuring this crucial #biomarker can accelerate your cutting-edge #research in #celltherapy.
Join our upcoming #IOdigest webinar, where Dr. Julian Ashby will dive deep into #NK cell biology and #therapies and showcase how #cellavidity is crucial in predicting #NK, #CARNK, #gammadeltaTcells, and #macrophage therapeutic efficacy.
Register now!➡️https://t.co/zQ2HRtO53w
Looking for the right tool for the identification and validation of effective #celltherapies? Watch this video on how #cellavidity measurements with the #zMovi Cell Avidity Analyzer may significantly accelerate cell product development. ⬇️
https://t.co/w3EpwugWSK
The #InnateKillerSummit kicks off today in London! Join our talk to learn how to enhance NK cell and other cell therapy efficacy with #cellavidity. Find us at our booth to discuss further.
Join our talk and meet us at booth #8 at the #IOSummit 2022 in Boston, MA, this week to discover how in vitro #CellAvidity measurement could predict the optimal in vivo response between tumor & effector cells and minimize #drugdiscovery timelines.
Wonder how #cellavidity measurement can help provide new insights into CAR T function, and enable CAR design optimization that can lead to better clinical outcomes? Join our next #IOdigest on 7 and 8 September to find out.⬇️
https://t.co/FWP6uZtxAJ
Wonder how #cellavidity measurement can help provide new insights into CAR T function, and enable CAR design optimization that can lead to better clinical outcomes? Join our next #IOdigest on 7 and 8 September to find out.⬇️
https://t.co/amIVlm1tn9
Learn from Dr. @MarcelaMaus, Director of Cellular Immunotherapy at @harvardmed, about novel CARs and the use of #cellavidity measurements to understand and enhance productive #CARTcell interactions with both liquid and solid #tumors. Download it here.
➡️https://t.co/QQKgCIbmO6
Last Seen Hashtags on Sotwe
Momson() +filter:native_video
Seen from Algeria
tsuchiyakeichi
Seen from United States
Cocacolajo
Seen from United States
阿黑颜
Seen from United States
yooahra
Seen from United States
RIZIN開幕戦
Seen from United States
ronarry
Seen from United States
CAFEPOLKA
Seen from United States
Beyourluve
Seen from United States
BonneCopine
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.1M followers
Taylor Swift
@taylorswift13
81.9M followers
Lady Gaga
@ladygaga
73.5M followers
Virat Kohli
@imvkohli
70.5M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.1M followers
Neymar Jr
@neymarjr
63.4M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61.2M followers
X
@x
60.8M followers